StockData
Silence Therapeutics plc logo

Silence Therapeutics plc (SLN) stock

SLNNasdaqPharmaceutical PreparationsAlso trades as SLNCF
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 7/30
$19.80+0.00 (0.00%)

Close on Nov 17, 2026Market cap $935.48MP/E –Yield –

Silence Therapeutics total assets

Total assets on the balance sheet at the end of each period.

Silence Therapeutics's total assets was $281.50M at Sep 30, 2026. For fiscal 2025 it was $131.44M, down 35.1% from the year before.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$131.44M-35.1%
FY2024Dec 31, 2024$202.64M+69.6%
FY2023Dec 31, 2023$119.45M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$281.50M+91.8%
Q2 FY2026Jun 30, 2026$106.41M-35.6%
Q1 FY2026Mar 31, 2026$115.12M-37.9%
Q4 FY2025Dec 31, 2025$131.44M-35.1%
Q3 FY2025Sep 30, 2025$146.79M+22.9%
Q2 FY2025Jun 30, 2025$165.23M–
Q1 FY2025Mar 31, 2025$185.30M–
Q4 FY2024Dec 31, 2024$202.64M–
Q4 FY2023Dec 31, 2023$119.45M–

More Silence Therapeutics figures

See a number that looks wrong?